Publications
Research is the foundation of meaningful medical advancement and improved autism care. Bahamas NeuroGen continues to contribute to scientific understanding through clinical observation, studies, and collaborations that inspire new possibilities for children and families.
Our Publications
A Global First in Autism Research
7th July, 2013
Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study
• This landmark publication is the world’s first to present clinical evidence on the use of autologous bone marrow mononuclear cell therapy for autism, marking a significant breakthrough in the field.
• It introduces a pioneering, regenerative approach that goes beyond conventional therapies, focusing on improving underlying neurological function.
• The study opens new pathways for future research while bringing renewed hope for better developmental outcomes and improved quality of life for individuals with autism.
7th July, 2013
Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study
World's Largest Cohort Study
91%
Patients Improved
- World's Largest Study From NeuroGen Showing Benefits Of Autologous Bone Marrow Mononuclear Cells In 1011 Children With Autism.
- 91% of patients improved.
- Comparison of pre- and post-therapy PET-CT scans in 401 patients demonstrated improved metabolic activity in multiple brain regions which correlated with the observed clinical improvements.
